Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

“Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives”. Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, Nicola Sverzellati, Sara Piciucchi, Diletta Cozzi, Valentina Luzzi, Camilla Comin and Athol U. Wells. Eur Respir Rev 2022; 31: 210206.

European Respiratory Review 2022 31: 215206; DOI: 10.1183/16000617.5206-2021
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Case of clinical evolution from interstitial lung abnormalities (ILA), early idiopathic pulmonary fibrosis (IPF) (subclinical), mild IPF and to advanced IPF. A 70-year-old man without risk factors for interstitial lung disease (ILD). He presented to the Forlì ILD Clinic, V. Poletti, for the incidental finding of ILA, was reclassified to early IPF after multidisciplinary revision of radiological and pathological findings on lung biopsy and during the follow-up evolved to mild IPF, advanced IPF and ultimately died of the disease. a) ILA. Incidental finding of reticular subpleural abnormalities with traction bronchiectasis. Pulmonary function tests: forced vital capacity (FVC) 129%, diffusing capacity of the lung for carbon monoxide (DLCO) 82%. No symptoms. b) Early IPF. The lung biopsy showed a definite usual interstitial pneumonia pattern and the case was reclassified as early IPF. c) Mild IPF. After 2 years of follow-up the DLCO dropped to 73%. The patient remained asymptomatic, with FVC around 120%. d) Advanced IPF. After 7 years of follow-up the FVC dropped to 60%, DLCO to 40% and the patient became symptomatic. The patient died after 10 years of follow-up.

  • FIGURE 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4

    Proposed algorithm for diagnosis and management of interstitial lung abnormalities (ILA), early interstitial lung disease (ILD) (both subclinical and pre-clinical) and mild ILD. BAL: bronchoalveolar lavage; CT: computed tomography; HRCT: high-resolution computed tomography; IPF: idiopathic pulmonary fibrosis; PFT: pulmonary function test; UIP: usual interstitial pneumonia.

Tables

  • Figures
  • TABLE 1

    Simplified definitions

    EntityPopulationDiagnostic criteriaDefinition
    ILAOnly individuals without known or suspected ILD#Clinical-radiological entityIncidental finding of CT abnormalities affecting more than 5% of any lung zone
    Early ILDPre-clinical ILDIndividuals at risk for ILDClinical-radiological-pathological entityAny ILD in asymptomatic patients with preserved lung function
    Subclinical ILDIndividuals NOT at risk for ILD
    Mild ILDAll individualsClinical-radiological-pathological entityAny clinically significant ILD with minor symptoms and/or trivial PFT abnormalities

    ILA: interstitial lung abnormalities; ILD: interstitial lung disease; CT: computed tomography; PFT: pulmonary function test. #: abnormalities identified during screening for ILD in high-risk groups (e.g. those with rheumatoid arthritis, systemic sclerosis or familial ILD) are not considered as ILA because they are not incidental.

    PreviousNext
    Back to top
    View this article with LENS
    Vol 31 Issue 164 Table of Contents
    European Respiratory Review: 31 (164)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    “Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives”. Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, Nicola Sverzellati, Sara Piciucchi, Diletta Cozzi, Valentina Luzzi, Camilla Comin and Athol U. W…
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    “Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives”. Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, Nicola Sverzellati, Sara Piciucchi, Diletta Cozzi, Valentina Luzzi, Camilla Comin and Athol U. Wells. Eur Respir Rev 2022; 31: 210206.
    European Respiratory Review Jun 2022, 31 (164) 215206; DOI: 10.1183/16000617.5206-2021

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    “Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives”. Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, Nicola Sverzellati, Sara Piciucchi, Diletta Cozzi, Valentina Luzzi, Camilla Comin and Athol U. Wells. Eur Respir Rev 2022; 31: 210206.
    European Respiratory Review Jun 2022, 31 (164) 215206; DOI: 10.1183/16000617.5206-2021
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • “Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis.” Ana Machado, Pedro Matos Silva, Vera Afreixo, Cátia Caneiras, Chris Burtin and Alda Marques. Eur Respir Rev 2020; 29: 200039.
    • “National and regional asthma programmes in Europe.” Olof Selroos, Maciej Kupczyk, Piotr Kuna, Piotr Łacwik, Jean Bousquet, David Brennan, Susanna Palkonen, Javier Contreras, Mark FitzGerald, Gunilla Hedlin, Sebastian L. Johnston, Renaud Louis, Leanne Metcalf, Samantha Walker, Antonio Moreno-Galdó, Nikolaos G. Papadopoulos, José Rosado-Pinto, Pippa Powell and Tari Haahtela. Eur Respir Rev 2015; 24: 474-483.
    Show more Erratum

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERR

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising
    • Sponsorship

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN: 0905-9180
    Online ISSN: 1600-0617

    Copyright © 2023 by the European Respiratory Society